secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2022-06-02T23:59:59+00:00
Accession:  0001628280-22-016073
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Corcept shareholders reject amended 2012 incentive plan at annual meeting
-------------------------------------------------------------------------

- All nine director nominees elected, with votes ranging from 70.6M to 83.9M in favor.
- Amended 2012 Incentive Award Plan not approved: 39.2M for, 44.6M against, 0.4M abstain.
- Ratification of Ernst & Young as auditor for FY2022 approved with 96.4M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000162828022016073/0001628280-22-016073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000162828022016073/cort-20220531.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-016073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer